611 related articles for article (PubMed ID: 10904087)
1. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.
van Dongen JA; Voogd AC; Fentiman IS; Legrand C; Sylvester RJ; Tong D; van der Schueren E; Helle PA; van Zijl K; Bartelink H
J Natl Cancer Inst; 2000 Jul; 92(14):1143-50. PubMed ID: 10904087
[TBL] [Abstract][Full Text] [Related]
2. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial.
Litière S; Werutsky G; Fentiman IS; Rutgers E; Christiaens MR; Van Limbergen E; Baaijens MH; Bogaerts J; Bartelink H
Lancet Oncol; 2012 Apr; 13(4):412-9. PubMed ID: 22373563
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.
Abdulkarim BS; Cuartero J; Hanson J; Deschênes J; Lesniak D; Sabri S
J Clin Oncol; 2011 Jul; 29(21):2852-8. PubMed ID: 21670451
[TBL] [Abstract][Full Text] [Related]
4. [Conservative therapy of I and II stage breast cancer--successful alternative to modified radical mastectomy].
Parvanova VM; Pandova VV; Garanina ZM
Vopr Onkol; 2001; 47(1):45-8. PubMed ID: 11317534
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.
van Dongen JA; Bartelink H; Fentiman IS; Lerut T; Mignolet F; Olthuis G; van der Schueren E; Sylvester R; Tong D; Winter J
Eur J Cancer; 1992; 28A(4-5):801-5. PubMed ID: 1524898
[TBL] [Abstract][Full Text] [Related]
6. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
[TBL] [Abstract][Full Text] [Related]
7. Cost comparison of mastectomy versus breast-conserving therapy for early-stage breast cancer.
Barlow WE; Taplin SH; Yoshida CK; Buist DS; Seger D; Brown M
J Natl Cancer Inst; 2001 Mar; 93(6):447-55. PubMed ID: 11259470
[TBL] [Abstract][Full Text] [Related]
8. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results.
Jatoi I; Proschan MA
Am J Clin Oncol; 2005 Jun; 28(3):289-94. PubMed ID: 15923803
[TBL] [Abstract][Full Text] [Related]
9. Breast-conserving therapy versus mastectomy in T1-2N2 stage breast cancer: a population-based study on 10-year overall, relative, and distant metastasis-free survival in 3071 patients.
van Maaren MC; de Munck L; Jobsen JJ; Poortmans P; de Bock GH; Siesling S; Strobbe LJA
Breast Cancer Res Treat; 2016 Dec; 160(3):511-521. PubMed ID: 27730424
[TBL] [Abstract][Full Text] [Related]
10. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
Fodor J
Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
[TBL] [Abstract][Full Text] [Related]
11. Is mastectomy superior to breast-conserving treatment for young women?
Coulombe G; Tyldesley S; Speers C; Paltiel C; Aquino-Parsons C; Bernstein V; Truong PT; Keyes M; Olivotto IA
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1282-90. PubMed ID: 17275207
[TBL] [Abstract][Full Text] [Related]
12. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
13. Breast conserving therapy in stage I & II breast cancer in Korea.
Lee HD; Yoon DS; Koo JY; Suh CO; Jung WH; Oh KK
Breast Cancer Res Treat; 1997 Jul; 44(3):193-9. PubMed ID: 9266098
[TBL] [Abstract][Full Text] [Related]
14. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
15. Twenty-five year results of the national cancer institute randomized breast conservation trial.
Simone NL; Dan T; Shih J; Smith SL; Sciuto L; Lita E; Lippman ME; Glatstein E; Swain SM; Danforth DN; Camphausen K
Breast Cancer Res Treat; 2012 Feb; 132(1):197-203. PubMed ID: 22113254
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.
Vargas C; Kestin L; Go N; Krauss D; Chen P; Goldstein N; Martinez A; Vicini FA
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1514-21. PubMed ID: 16005576
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements.
Faverly DR; Hendriks JH; Holland R
Cancer; 2001 Feb; 91(4):647-59. PubMed ID: 11241230
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes among breast cancer patients with extensive regional lymph node involvement: implications for locoregional management.
Braunstein LZ; Galland-Girodet S; Goldberg S; Warren LE; Sadek BT; Shenouda MN; Abi-Raad RF; MacDonald SM; Taghian AG
Breast Cancer Res Treat; 2015 Dec; 154(3):633-9. PubMed ID: 26585579
[TBL] [Abstract][Full Text] [Related]
19. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
20. Breast conservation versus mastectomy for patients with T3 primary tumors (>5 cm): A review of 5685 medicare patients.
Bleicher RJ; Ruth K; Sigurdson ER; Daly JM; Boraas M; Anderson PR; Egleston BL
Cancer; 2016 Jan; 122(1):42-9. PubMed ID: 26479066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
